Unlike our findings in melanoma, IGF2R has been described to be a tumor suppressor in gastrointestinal and breast cancer17,18, we therefore investigated the consequences of blocking the hydrolase transport machinery on non-melanoma cancer types. The gene discussed is IGF2R; the disease is melanoma.